Your search for high-quality, complimentary CME/CE stops right here. The courses below are presented by myCME, the continuing education engine in Haymarket Medical Network’s (HMN) expanding portfolio of clinical websites. Below you’ll find practice-relevant courses that carry valuable CME/CE credit. Simply click any link to get started earning credit on myCME.
Featured Courses
Endoscopic Cryotherapy Abscopal Effect | myCME
1.00 CME: Current uses and evidence behind some endoscopic cancer ablative therapy. Presents novel research on emerging endoscopic ablative therapies. Exp 12/8/23
State of the Art Management of IBS-C | myCME
0.75 CME: This course provides vital information on the management of patients with IBS-C through a case-based scenario. Exp 2/3/24
An Update on IBD Pivotal Clinical Trials | myCME
CME CE 1.50: Summary and overview of Inflammatory Bowel Disease (IBD) pivotal clinical trials from the United European Gastroenterology Week (UEGW) 2022 and the American College of Gastroenterology (ACG) 2022 conferences. Exp 1/18/24
Team-Based Preventive Health Maintenance in IBD | myCME
1.00 CME CE: After completion of this Adaptive Learning OnDemand activity, learners will be able to manage and maintain preventive health maintenance in IBD. Exp 1/18/24
Role of Chemoradiation after Endoscopic Resection | myCME
1.50 CME: Reviews genetic basis of hereditary cancers, identification of patients at risk, cancer risks, and medical management guidelines. Exp 12/8/23
ACLF and Acute Kidney Injury in Cirrhosis | myCME
1.00 CME CE: Acute-on-Chronic liver failure and multi-organ disease. Exp 1/26/24
Gastroenterology: Tactics to Address Health Inequities | myCME
0.75 CME CE: Case reflective of the impact of biases, disparities, and health inequities that exist in racial and ethnic underserved patients with IBD. Exp. 3/17/24
Benefitting from Biosimilars | myCME
1.50 CME CE: This 90-minute virtual activity will focus on understanding the best practices for using biosimilars when managing inflammatory conditions. Exp 5/31/24
Latest Updates in IBS Treatment for Your Practice | myCME
0.50 CME CE: Incorporating IBS-C and CIC guidelines into practice; managing IBS-C and CIC; the gut-brain axis in functional gastrointestinal disorders. Exp 7/31/24
Improving Treatment for Primary Biliary Cholangitis | myCME
0.50 CME: Kris Kowdley, MD, leads HCPs through cases that address treatment options, symptom burden, and emerging treatment in PBC. Exp 7/26/24
Advances in Managing Eosinophilic Esophagitis | myCME
0.50 CME: Addresses several unmet needs in EoE diagnosis and treatment through a Q&A format with practicing clinicians citing relevant clinical data. Exp 7/28/24
Integrating Biosimilars into Conversations With Patients | myCME
1.50 CME: Experts discuss biologics and biosimilars for inflammatory conditions, patient-provider interaction, and team-based shared decision-making. Exp 6/30/24
